Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 837620

Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?


Mance, Davor; Mance, Diana; Vitezić, Dinko
Pharmaceutical Pricing: How Much for The Risk Of Non-Cure? // Clinical Therapeutics, Volume 38, Issue 10, Supplement, 6 October 2016,
Opatija, Hrvatska: Elsevier, 2016. str. 17-18 doi:10.1016/j.clinthera.2016.07.128 (predavanje, nije recenziran, sažetak, znanstveni)


CROSBI ID: 837620 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?

Autori
Mance, Davor ; Mance, Diana ; Vitezić, Dinko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Clinical Therapeutics, Volume 38, Issue 10, Supplement, 6 October 2016, / - : Elsevier, 2016, 17-18

Skup
European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment

Mjesto i datum
Opatija, Hrvatska, 06.10.2016. - 09.10.2016

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
Pharmacoeconomics ; Pharmaceutical Pricing ; Risk Of Non-Cure ; Sustained Virological Response

Sažetak
Pharmacoeconomics is a blend of economic methodology with clinical pharmacology and outcomes research with an objective to provide for more efficient and cost-effective treatments. By doing this, pharmacoeconomics is constantly faced with ethical decision-making problems. The problem lies with the attempt of using epistemologically objective methods on an intrinsically ontologically subjective subject matter. In this work we discuss the possibility of an epistemologically objective methodology of integration of measures of risk of non-cure into pharmaceutical pricing schemes.

Izvorni jezik
Engleski

Znanstvena područja
Matematika, Kliničke medicinske znanosti, Ekonomija



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Ekonomski fakultet, Rijeka,
Sveučilište u Rijeci - Odjel za fiziku

Profili:

Avatar Url Diana Mance (autor)

Avatar Url Davor Mance (autor)

Avatar Url Dinko Vitezić (autor)

Poveznice na cjeloviti tekst rada:

doi www.clinicaltherapeutics.com www.sciencedirect.com

Citiraj ovu publikaciju:

Mance, Davor; Mance, Diana; Vitezić, Dinko
Pharmaceutical Pricing: How Much for The Risk Of Non-Cure? // Clinical Therapeutics, Volume 38, Issue 10, Supplement, 6 October 2016,
Opatija, Hrvatska: Elsevier, 2016. str. 17-18 doi:10.1016/j.clinthera.2016.07.128 (predavanje, nije recenziran, sažetak, znanstveni)
Mance, D., Mance, D. & Vitezić, D. (2016) Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?. U: Clinical Therapeutics, Volume 38, Issue 10, Supplement, 6 October 2016, doi:10.1016/j.clinthera.2016.07.128.
@article{article, author = {Mance, Davor and Mance, Diana and Vitezi\'{c}, Dinko}, year = {2016}, pages = {17-18}, DOI = {10.1016/j.clinthera.2016.07.128}, keywords = {Pharmacoeconomics, Pharmaceutical Pricing, Risk Of Non-Cure, Sustained Virological Response}, doi = {10.1016/j.clinthera.2016.07.128}, title = {Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?}, keyword = {Pharmacoeconomics, Pharmaceutical Pricing, Risk Of Non-Cure, Sustained Virological Response}, publisher = {Elsevier}, publisherplace = {Opatija, Hrvatska} }
@article{article, author = {Mance, Davor and Mance, Diana and Vitezi\'{c}, Dinko}, year = {2016}, pages = {17-18}, DOI = {10.1016/j.clinthera.2016.07.128}, keywords = {Pharmacoeconomics, Pharmaceutical Pricing, Risk Of Non-Cure, Sustained Virological Response}, doi = {10.1016/j.clinthera.2016.07.128}, title = {Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?}, keyword = {Pharmacoeconomics, Pharmaceutical Pricing, Risk Of Non-Cure, Sustained Virological Response}, publisher = {Elsevier}, publisherplace = {Opatija, Hrvatska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font